Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer-Reference-Cited by-同舟云学术

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Published:2017-11 Issue:10 Volume:28 Page:1086-1096
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Leonard Shannon C.,Lee Helen,Gaddy Daniel F.,Klinz Stephan G.,Paz Nancy,Kalra Ashish V.,Drummond Daryl C.,Chan Daniel C.,Bunn Paul A.,Fitzgerald Jonathan B.,Hendriks Bart S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference36 articles.

1. Treatment of small cell lung cancer;Morabito;Crit Rev Oncol Hematol,2014

2. Small cell lung cancer: are we making progress?;Dowell;Am J Med Sci,2010

3. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Fruh;Ann Oncol,2013

4. Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial;Hermes;J Clin Oncol,2008

5. A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer;Jiang;J Thorac Oncol,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma;Journal of Photochemistry and Photobiology B: Biology;2024-06

2. Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature;Journal of Gastrointestinal Oncology;2023-02

3. Drug Stability and Minimized Acid-/Drug-Catalyzed Phospholipid Degradation in Liposomal Irinotecan;Journal of Pharmaceutical Sciences;2023-02

4. The Development of Investigator-Initiated Clinical Trials in Surgical Oncology;Surgical Oncology Clinics of North America;2023-01

5. A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease;Annals of Surgical Oncology;2022-11-07